Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 100.3 SEK -0.69%
Market Cap: 9.8B SEK

During the last 3 months Biogaia AB insiders have not bought any shares, and sold 78k SEK worth of shares. The stock price has dropped by 16% over this period (open performance analysis).

The last transaction was made on Feb 12, 2025 by Linda Hägglund (Chief Financial Officer (CFO)) , who sold 56.8k SEK worth of BIOG B shares.

Last Transactions:
Linda Hägglund
Chief Financial Officer (CFO)
kr-21.2k
Linda Hägglund
Chief Financial Officer (CFO)
kr-56.8k
Anthon Jahreskog
CEO
kr+134.9k
Linda Hägglund
Chief Financial Officer (CFO)
kr-233.8k
Linda Hägglund
Chief Financial Officer (CFO)
kr-115.5k
Linda Hägglund
Chief Financial Officer (CFO)
kr-697.8
Linda Hägglund
Chief Financial Officer (CFO)
kr-58.1k
Alexander Kotsinas
Chief Financial Officer
kr-11.3m
Linda Hägglund
Chief Financial Officer (CFO)
kr+578.2k
Linda Hägglund
Chief Financial Officer (CFO)
kr+55.6k
Alexander Kotsinas
Chief Financial Officer
kr+11m
Outi Armstrong
Director of Marketing
kr+125.4k
Anthon Jahreskog
CEO
kr+142.6k
Anthon Jahreskog
CEO
kr+18.1k
Anthon Jahreskog
CEO
kr+51.5k
View All Transactions

During the last 3 months Biogaia AB insiders have not bought any shares, and sold 78k SEK worth of shares. The stock price has dropped by 16% over this period (open performance analysis).

The last transaction was made on Feb 12, 2025 by Linda Hägglund (Chief Financial Officer (CFO)) , who sold 56.8k SEK worth of BIOG B shares.

Sold
0-3
months
78k SEK
1
3-6
months
0 SEK
0
6-9
months
11.7m SEK
2
9-12
months
0 SEK
0
Bought
0-3
months
0
0 SEK
3-6
months
1
134.9k SEK
6-9
months
2
11.6m SEK
9-12
months
2
268k SEK

Biogaia AB
Insider Trading Chart

Biogaia AB
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Biogaia AB
Last Insider Transactions

Global
Insiders Monitor

Biogaia AB
Glance View

Market Cap
10.1B SEK
Industry
Biotechnology

BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.

BIOG B Intrinsic Value
121.12 SEK
Undervaluation 17%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top